News
11-14-2014, 06:29 AM
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, today reported financial results for the three and nine months ended September 30, 2014.
More... (http://www.news-medical.net/news/20141114/CASI-Pharmaceuticals-announces-net-loss-of-24215M-in-third-quarter-2014.aspx)
More... (http://www.news-medical.net/news/20141114/CASI-Pharmaceuticals-announces-net-loss-of-24215M-in-third-quarter-2014.aspx)